Capricor Therapeutics
CAPR
CAPR
30 hedge funds and large institutions have $20.5M invested in Capricor Therapeutics in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
36% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $1.62M
Holders
30
Holding in Top 10
–
Calls
$1.04M
Puts
$1.62M
Top Buyers
| 1 | +$9.36M | |
| 2 | +$2.84M | |
| 3 | +$1.26M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$232K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$192K |
Top Sellers
| 1 | -$303K | |
| 2 | -$186K | |
| 3 | -$126K | |
| 4 |
Morgan Stanley
New York
|
-$118K |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$54K |